Lexicon director exercises 89,312 RSUs into shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LEXICON PHARMACEUTICALS, INC. director Judith L. Swain exercised restricted stock units into common shares. She acquired 89,312 shares of common stock at a stated price of $0.00 per share through the conversion of restricted stock units. Following this transaction, she directly holds 174,486 common shares. The restricted stock units represented a contingent right to receive one common share per unit and vested in full on the first anniversary of the grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 89,312 | $0.00 | $0.00 |
| Exercise | Common Stock | 89,312 | $0.00 | $0.00 |
Footnotes (2)
- F1. Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- F2. Each restricted stock unit represents a contingent right to receive one share of common stock.
Key Figures
Key Terms
Restricted Stock Units financial
Exercise or conversion of derivative security financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Lexicon Pharmaceuticals (LXRX) report for Judith L. Swain?
What do the restricted stock units (RSUs) in the Lexicon Pharmaceuticals (LXRX) Form 4 represent?
Did Judith L. Swain retain any restricted stock units (RSUs) in Lexicon Pharmaceuticals (LXRX) after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.